Manning & Napier Advisors LLC Trims Stake in The Cooper Companies, Inc. $COO

Manning & Napier Advisors LLC reduced its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 7.7% during the first quarter, Holdings Channel.com reports. The fund owned 1,443,901 shares of the medical device company’s stock after selling 120,125 shares during the quarter. Cooper Companies accounts for 1.5% of Manning & Napier Advisors LLC’s investment portfolio, making the stock its 18th largest holding. Manning & Napier Advisors LLC’s holdings in Cooper Companies were worth $103,239,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of COO. Hsbc Holdings PLC boosted its position in shares of Cooper Companies by 12.2% during the 1st quarter. Hsbc Holdings PLC now owns 403,103 shares of the medical device company’s stock valued at $28,755,000 after acquiring an additional 43,812 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Cooper Companies by 1.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 439,109 shares of the medical device company’s stock worth $31,396,000 after purchasing an additional 5,868 shares during the last quarter. Munich Reinsurance Co Stock Corp in Munich purchased a new stake in Cooper Companies in the first quarter valued at approximately $3,666,000. DGS Capital Management LLC bought a new stake in Cooper Companies during the first quarter valued at approximately $229,000. Finally, HB Wealth Management LLC lifted its position in Cooper Companies by 72.2% during the first quarter. HB Wealth Management LLC now owns 7,120 shares of the medical device company’s stock valued at $509,000 after purchasing an additional 2,985 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

COO traded down $0.32 during midday trading on Friday, hitting $70.70. The stock had a trading volume of 1,413,143 shares, compared to its average volume of 2,835,672. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The business has a fifty day moving average of $65.26 and a 200 day moving average of $73.00. The company has a market cap of $13.79 billion, a P/E ratio of 59.92, a price-to-earnings-growth ratio of 1.86 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently commented on COO. Citigroup reissued a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a report on Wednesday. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Piper Sandler set a $86.00 target price on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. Finally, BNP Paribas Exane lowered their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $81.85.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.